ROYCE & ASSOCIATES LP

Position in ANGO — Angiodynamics Inc

CIK 906304 New York, NY

Position in ANGO

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$17,384,172

+$1,110,102 QoQ

Shares Held

1,528,951

+20.6% QoQ

Ownership

3.70%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ROYCE & ASSOCIATES LP holds $114,889,031 across 12 Medical Instruments & Supplies names. ANGO ranks #2 (15.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVST	Envista Holdings Corp	978,447	$24,823,200
2	ANGO	Angiodynamics Inc This page	1,528,951	$17,384,172
3	RGEN	Repligen Corp	115,932	$13,659,108
4	STVN	Stevanato Group S.p.A.	841,326	$11,568,232
5	AVTR	Avantor, Inc.	1,463,622	$11,474,796
6	BLFS	Biolife Solutions Inc	584,011	$11,142,929
7	AZTA	Azenta, Inc.	523,308	$11,057,498
8	TFX	Teleflex Inc	55,530	$6,641,943

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,384,172	1,528,951	+20.6%	Shares	Sole	2026-05-12
2025-12-31	$16,274,070	1,267,451	+27.3%	Shares	Sole	2026-02-09
2025-09-30	$11,118,171	995,360	+1.7%	Shares	Sole	2025-11-12
2025-06-30	$9,707,315	978,560	-4.8%	Shares	Sole	2025-08-11
2025-03-31	$9,649,445	1,027,630	-8.2%	Shares	Sole	2025-05-06
2024-12-31	$10,253,566	1,119,385	+13.5%	Shares	Sole	2025-02-10
2024-09-30	$7,671,647	986,073	+10.8%	Shares	Sole	2024-11-06
2024-06-30	$5,384,106	889,935	+72.8%	Shares	Sole	2024-08-13
2024-03-31	$3,022,668	514,935	+187.3%	Shares	Sole	2024-05-13
2020-09-30	$2,161,453	179,225	-49.3%	Shares	Sole	2020-11-12
2020-06-30	$3,593,772	353,370	-9.9%	Shares	Sole	2020-08-07
2020-03-31	$4,089,018	392,044	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.